Search





Search





Markets
/
Stocks
/
cycn
/

Cyclerion Therapeutics Inc

CYCN

Add to Watchlist

3.440USD

-0.060-1.71%

Close 07-31 16:00（ET）Quotes delayed by 15 min

14.59MMarket Cap

LossP/E TTM

Cyclerion Therapeutics Inc

3.440

-0.060-1.71%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CYCN Cash Flow Statement

You can access the annual and quarterly cash flow statements of Cyclerion Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2017Q4

FY2017Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-21.49%-1.18M

-538.61%-1.58M

84.62%-264.00K

54.52%-503.00K

48.26%-968.00K

123.36%360.00K

75.26%-1.72M

83.13%-1.11M

69.89%-1.87M

78.12%-1.54M

30.06%-6.94M

39.41%-6.55M

51.59%-6.21M

18.39%-7.04M

-25.14%-9.91M

-96.37%-10.82M

11.21%-12.84M

38.54%-8.63M

47.35%-7.92M

61.26%-5.51M

50.46%-14.46M

36.65%-14.04M

36.80%-15.05M

35.27%-14.22M

14.86%-29.18M

4.27%-22.16M

5.90%-23.81M

---21.97M

---34.27M

10.24%-23.15M

-24.01%-25.30M

---25.79M

---20.40M

Net income from continuing operations

-122.32%-3.18M

-250.75%-799.00K

-34.99%-976.00K

75.49%-324.00K

7.33%-1.43M

131.29%530.00K

-109.56%-723.00K

68.38%-1.32M

77.83%-1.54M

76.52%-1.69M

172.08%7.57M

68.77%-4.18M

46.42%-6.95M

33.03%-7.22M

7.04%-10.50M

17.27%-13.39M

3.14%-12.98M

43.96%-10.78M

39.98%-11.29M

17.16%-16.18M

33.76%-13.40M

26.20%-19.23M

31.14%-18.81M

39.44%-19.53M

45.89%-20.23M

15.69%-26.05M

6.72%-27.32M

---32.25M

---37.38M

-11.74%-30.90M

-16.28%-29.29M

---27.66M

---25.19M

Operating gains losses

----

--0.00

----

--0.00

--3.30M

-100.00%0.00

-85.59%17.00K

-81.40%48.00K

-89.79%48.00K

-91.84%48.00K

-80.75%118.00K

-58.79%258.00K

-28.02%470.00K

-15.64%588.00K

-25.70%613.00K

19.24%626.00K

40.13%653.00K

105.00%697.00K

--825.00K

--525.00K

26.29%466.00K

7.94%340.00K

--369.00K

--315.00K

Other non-cash items

----

--0.00

----

--0.00

---363.00K

----

100.00%0.00

--0.00

----

---3.56M

100.00%0.00

--881.00K

----

--0.00

---2.43M

--0.00

---2.11M

----

Change in working capital

459.94%1.94M

-199.66%-875.00K

177.34%594.00K

-1015.63%-293.00K

168.04%347.00K

-684.00%-292.00K

65.28%-768.00K

101.16%32.00K

-262.42%-510.00K

105.26%50.00K

-104.63%-2.21M

-422.37%-2.75M

118.78%314.00K

-130.54%-951.00K

-219.05%-1.08M

-14.60%854.00K

53.74%-1.67M

100.13%3.11M

-49.56%908.00K

95.31%1.00M

68.46%-3.61M

181.64%1.56M

181.26%1.80M

-84.18%512.00K

-716.24%-11.46M

-151.86%-1.91M

-769.18%-2.21M

--3.24M

---1.40M

665.38%3.67M

-81.71%331.00K

---650.00K

--1.81M

-Change in receivables

4100.00%1.00M

-75.78%-900.00K

1065.91%425.00K

--56.00K

---25.00K

---512.00K

---44.00K

----

-100.00%0.00

--0.00

--96.00K

100.00%0.00

125.86%131.00K

100.00%0.00

--0.00

-200.00%-127.00K

-78.68%58.00K

-145.01%-158.00K

-100.00%0.00

-71.65%127.00K

900.00%272.00K

-15.83%351.00K

114.81%275.00K

--448.00K

---34.00K

--417.00K

---1.86M

----

-Change in prepaid expenses

-21.82%129.00K

-99.00%2.00K

115.05%76.00K

-207.29%-206.00K

23.13%165.00K

-29.58%200.00K

-258.81%-505.00K

140.25%192.00K

-43.70%134.00K

205.58%284.00K

186.49%318.00K

-232.50%-477.00K

401.27%238.00K

26.50%-269.00K

-45.59%111.00K

-19.28%360.00K

80.05%-79.00K

-191.04%-366.00K

-80.42%204.00K

213.78%446.00K

-504.08%-396.00K

103.03%402.00K

369.95%1.04M

53.94%-392.00K

263.33%98.00K

218.56%198.00K

-227.81%-386.00K

---851.00K

---60.00K

42.61%-167.00K

159.57%302.00K

---291.00K

---507.00K

-Change in other current assets

100.00%0.00

--16.00K

---6.00K

---5.00K

-123.81%-5.00K

-100.00%0.00

-76.40%21.00K

-41.98%76.00K

59.40%212.00K

34.38%172.00K

-30.47%89.00K

670.59%131.00K

-66.83%133.00K

-87.26%128.00K

-87.67%128.00K

-97.85%17.00K

-39.43%401.00K

116.67%1.00M

150.12%1.04M

-21.34%789.00K

-38.42%662.00K

-100600.00%-6.03M

157.76%415.00K

1553.62%1.00M

--1.07M

--6.00K

1250.00%161.00K

-76.92%-69.00K

---14.00K

---39.00K

-Change in other current liabilities

----

-100.00%0.00

----

---52.00K

--52.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-21.49%-1.18M

-538.61%-1.58M

84.62%-264.00K

54.52%-503.00K

48.26%-968.00K

123.36%360.00K

75.26%-1.72M

83.13%-1.11M

69.89%-1.87M

78.12%-1.54M

30.06%-6.94M

39.41%-6.55M

51.59%-6.21M

18.39%-7.04M

-25.14%-9.91M

-96.37%-10.82M

11.21%-12.84M

38.54%-8.63M

47.35%-7.92M

61.26%-5.51M

50.46%-14.46M

36.65%-14.04M

36.80%-15.05M

35.27%-14.22M

14.86%-29.18M

4.27%-22.16M

5.90%-23.81M

---21.97M

---34.27M

10.24%-23.15M

-24.01%-25.30M

---25.79M

---20.40M

Investing cash flow

Net cash from continuing investing activities

--66.00K

----

--0.00

----

--0.00

---10.40M

----

--0.00

-100.00%0.00

100.00%0.00

333.33%7.00K

-103.08%-2.00K

-207.82%-1.46M

-1536.00%-1.44M

-100.54%-3.00K

-98.47%65.00K

-25.25%1.36M

-94.49%100.00K

-52.24%554.00K

--4.25M

--1.81M

316.51%1.82M

48.53%1.16M

--436.00K

--781.00K

Capital expenditures

--66.00K

----

--0.00

----

-100.00%0.00

-22.22%7.00K

-100.00%0.00

-79.89%35.00K

-98.62%9.00K

-98.23%75.00K

-22.55%1.41M

-90.42%174.00K

-43.71%653.00K

--4.25M

--1.81M

316.51%1.82M

48.53%1.16M

--436.00K

--781.00K

Net cash flow from disposal of fixed assets

--66.00K

----

--0.00

----

--0.00

---10.40M

----

--0.00

-100.00%0.00

100.00%0.00

333.33%7.00K

-103.08%-2.00K

-207.82%-1.46M

-1536.00%-1.44M

-100.54%-3.00K

-98.47%65.00K

-25.25%1.36M

-94.49%100.00K

-52.24%554.00K

--4.25M

--1.81M

316.51%1.82M

48.53%1.16M

--436.00K

--781.00K

Net cash flow from other investing activities

--0.00

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

---66.00K

----

--0.00

-100.00%0.00

----

--0.00

--10.40M

----

--0.00

100.00%0.00

-100.00%0.00

-333.33%-7.00K

103.08%2.00K

207.82%1.46M

1536.00%1.44M

100.54%3.00K

98.47%-65.00K

25.25%-1.36M

94.49%-100.00K

52.24%-554.00K

---4.25M

---1.81M

-316.51%-1.82M

-48.53%-1.16M

---436.00K

---781.00K

Financing cash flow

Cash flow from continuous financing activities

-40.00%825.00K

--251.00K

--1.83M

---130.00K

--1.38M

--0.00

----

-100.00%0.00

--0.00

29452.94%5.02M

----

-85.88%12.00K

-100.00%0.00

-99.94%17.00K

-100.00%0.00

-46.54%85.00K

-99.82%43.00K

736.20%30.63M

2600.00%27.00K

9.66%159.00K

6548.49%24.27M

-97.91%3.66M

-100.00%1.00K

-99.42%145.00K

-98.62%365.00K

--174.98M

--36.09M

-4.81%24.97M

24.92%26.46M

--26.23M

--21.18M

Net cash flow from debt Issuance/repayment

----

--0.00

-100.00%0.00

----

--0.00

--3.51M

----

Net cash flow from common stock issuance/repurchase

-40.00%825.00K

--251.00K

--1.83M

--0.00

--1.38M

--0.00

----

--0.00

--5.00M

----

--0.00

-100.00%0.00

----

--0.00

-99.98%6.00K

--30.50M

----

--0.00

--24.25M

-100.00%0.00

----

--0.00

--175.00M

----

Proceeds from stock option exercised by employees

----

--0.00

----

-100.00%0.00

--0.00

41.18%24.00K

----

-85.88%12.00K

-100.00%0.00

-87.22%17.00K

-100.00%0.00

-46.54%85.00K

117.65%37.00K

-13.64%133.00K

2600.00%27.00K

9.66%159.00K

-95.34%17.00K

--154.00K

--1.00K

--145.00K

--365.00K

----

Net cash flow from other financing activities

--0.00

---130.00K

----

--0.00

----

--0.00

100.00%0.00

----

-100.00%0.00

---24.00K

--36.09M

-4.81%24.97M

24.92%26.46M

--26.23M

--21.18M

Net cash from non-recurrent financing activities

Net cash from financing activities

-40.00%825.00K

--251.00K

--1.83M

---130.00K

--1.38M

--0.00

----

-100.00%0.00

--0.00

29452.94%5.02M

----

-85.88%12.00K

-100.00%0.00

-99.94%17.00K

-100.00%0.00

-46.54%85.00K

-99.82%43.00K

736.20%30.63M

2600.00%27.00K

9.66%159.00K

6548.49%24.27M

-97.91%3.66M

-100.00%1.00K

-99.42%145.00K

-98.62%365.00K

--174.98M

--36.09M

-4.81%24.97M

24.92%26.46M

--26.23M

--21.18M

Net cash flow

Beginning cash balance

0.25%3.24M

59.05%4.57M

-34.48%3.01M

-36.11%3.64M

-57.31%3.23M

-68.47%2.87M

-18.67%4.59M

-20.55%5.70M

-43.42%7.57M

-55.36%9.11M

-81.40%5.64M

-82.57%7.17M

-75.20%13.38M

-67.35%20.41M

-56.92%30.32M

-9.15%41.13M

-7.33%53.96M

--62.50M

14.54%70.39M

-37.21%45.27M

-43.25%58.23M

-100.00%0.00

-58.69%61.45M

--72.09M

--102.62M

--124.76M

--148.76M

--0.00

Current period cash flow changes

-202.46%-417.00K

-468.89%-1.33M

191.03%1.56M

42.87%-633.00K

121.71%407.00K

123.42%360.00K

-149.50%-1.72M

27.49%-1.11M

69.82%-1.88M

78.11%-1.54M

134.96%3.47M

85.85%-1.53M

51.60%-6.21M

17.78%-7.02M

-25.75%-9.92M

-142.99%-10.80M

1.00%-12.84M

31.37%-8.54M

-185.50%-7.89M

336.24%25.12M

57.53%-12.97M

43.78%-12.45M

138.44%9.22M

-107.15%-10.63M

---30.53M

---22.14M

---24.00M

--148.76M

--0.00

Effect of exchange rate changes

----

--0.00

100.00%0.00

-100.00%0.00

--0.00

-166.67%-2.00K

-500.00%-4.00K

-50.00%4.00K

100.00%0.00

400.00%3.00K

200.00%1.00K

166.67%8.00K

---3.00K

-200.00%-1.00K

---1.00K

--3.00K

-100.00%0.00

108.33%1.00K

----

100.00%0.00

-40.00%3.00K

-200.00%-12.00K

--2.00K

---21.00K

--5.00K

---4.00K

----

Ending cash balance

-22.42%2.82M

0.25%3.24M

59.05%4.57M

-34.48%3.01M

-36.11%3.64M

-57.31%3.23M

-68.47%2.87M

-18.67%4.59M

-20.55%5.70M

-43.42%7.57M

-55.36%9.11M

-81.40%5.64M

-82.57%7.17M

-75.20%13.38M

-67.35%20.41M

-56.92%30.32M

-9.15%41.13M

533.56%53.96M

-11.57%62.50M

14.54%70.39M

-37.21%45.27M

-112.13%-12.45M

-43.35%70.68M

-58.69%61.45M

--72.09M

--102.62M

--124.76M

--148.76M

--0.00

Free cash flow

---1.24M

----

123.36%360.00K

----

78.12%-1.54M

30.06%-6.94M

----

18.39%-7.04M

-25.03%-9.91M

-96.37%-10.82M

11.21%-12.84M

38.69%-8.63M

47.33%-7.93M

61.46%-5.51M

52.74%-14.46M

36.98%-14.08M

38.45%-15.06M

45.47%-14.30M

15.24%-30.59M

10.54%-22.34M

7.55%-24.46M

---26.22M

---36.09M

4.81%-24.97M

-24.92%-26.46M

---26.23M

---21.18M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Cyclerion Therapeutics Inc Generate?



Cyclerion Therapeutics Inc generated -3.31M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Cyclerion Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Cyclerion Therapeutics Inc's operating cash flow increased by 23.52% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Cyclerion Therapeutics Inc's Financing Cash Flow Changed?



Cyclerion Therapeutics Inc used 3.32M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CYCN?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.